127 related articles for article (PubMed ID: 7622293)
1. Purine enzyme profile in human colon-carcinoma cell lines and differential sensitivity to deoxycoformycin and 2'-deoxyadenosine in combination.
Camici M; Turriani M; Tozzi MG; Turchi G; Cos J; Alemany C; Miralles A; Noe V; Ciudad CJ
Int J Cancer; 1995 Jul; 62(2):176-83. PubMed ID: 7622293
[TBL] [Abstract][Full Text] [Related]
2. Deoxyadenosine metabolism in a human colon-carcinoma cell line (LoVo) in relation to its cytotoxic effect in combination with deoxycoformycin.
Bemi V; Tazzni N; Banditelli S; Giorgelli F; Pesi R; Turchi G; Mattana A; Sgarrella F; Tozzi MG; Camici M
Int J Cancer; 1998 Mar; 75(5):713-20. PubMed ID: 9495239
[TBL] [Abstract][Full Text] [Related]
3. Adenosine-mediated killing of cultured epithelial cancer cells.
Barry CP; Lind SE
Cancer Res; 2000 Apr; 60(7):1887-94. PubMed ID: 10766176
[TBL] [Abstract][Full Text] [Related]
4. Resistance of an adenosine kinase-deficient human lymphoblastoid cell line to effects of deoxyadenosine on growth, S-adenosylhomocysteine hydrolase inactivation, and dATP accumulation.
Hershfield MS; Kredich NM
Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4292-6. PubMed ID: 6254019
[TBL] [Abstract][Full Text] [Related]
5. Characterization of three T-lymphoid cell lines with distinct sensitivities to deoxyadenosine plus deoxycoformycin.
Duan DS; Smith W; Sadée W; Cowan MJ
Thymus; 1992 Feb; 19(1):1-11. PubMed ID: 1373528
[TBL] [Abstract][Full Text] [Related]
6. Resistance of pokeweed mitogen-stimulated B cells to inhibition by deoxyadenosine.
Hayward AR
Clin Exp Immunol; 1980 Jul; 41(1):141-9. PubMed ID: 6969149
[TBL] [Abstract][Full Text] [Related]
7. Role of the phosphorolysis of deoxyadenosine in the cytotoxic effect of the combination of deoxyadenosine and deoxycoformycin on a human colon carcinoma cell line (LoVo).
Giorgelli F; Giannecchini M; Bemi V; Turchi G; Sgarrella F; Tozzi MG; Camici M
J Cell Biochem; 2000 Oct; 80(2):241-7. PubMed ID: 11074595
[TBL] [Abstract][Full Text] [Related]
8. Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia.
Kurtzberg J; Hershfield MS
Cancer Res; 1985 Apr; 45(4):1579-86. PubMed ID: 3872167
[TBL] [Abstract][Full Text] [Related]
9. Deoxynucleoside induces neuronal apoptosis independent of neurotrophic factors.
Wakade AR; Przywara DA; Palmer KC; Kulkarni JS; Wakade TD
J Biol Chem; 1995 Jul; 270(30):17986-92. PubMed ID: 7629106
[TBL] [Abstract][Full Text] [Related]
10. Adenosine analogs as possible differentiation-inducing agents against acute myeloid leukemia.
Niitsu N; Honma Y
Leuk Lymphoma; 1999 Jul; 34(3-4):261-71. PubMed ID: 10439363
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of adenosine and deoxyadenosine by human erythrocytes and CCRF-CEM leukemia cells.
Szabados E; Duggleby RG; Christopherson RI
Int J Biochem Cell Biol; 1996 Dec; 28(12):1405-15. PubMed ID: 9022297
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase.
Lee N; Russell N; Ganeshaguru K; Jackson BF; Piga A; Prentice HG; Foa R; Hoffbrand AV
Br J Haematol; 1984 Jan; 56(1):107-19. PubMed ID: 6231047
[TBL] [Abstract][Full Text] [Related]
13. S-adenosylhomocysteine catabolism and basis for acquired resistance during treatment of T-cell acute lymphoblastic leukemia with 2'-deoxycoformycin alone and in combination with 9-beta-D-arabinofuranosyladenine.
Hershfield MS; Kredich NM; Koller CA; Mitchell BS; Kurtzberg J; Kinney TR; Falletta JM
Cancer Res; 1983 Jul; 43(7):3451-8. PubMed ID: 6601986
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity of deoxycoformycin on human colon carcinoma cell lines.
Camici M; Turriani M; Turchi G; Tozzi MG; Cos J; Alemany C; Noe V; Ciudad CJ
Adv Exp Med Biol; 1994; 370():275-8. PubMed ID: 7660907
[No Abstract] [Full Text] [Related]
15. Biochemical correlates of the differential sensitivity of subtypes of human leukemia to deoxyadenosine and deoxycoformycin.
Matsumoto SS; Yu AL; Bleeker LC; Bakay B; Kung FH; Nyhan WL
Blood; 1982 Nov; 60(5):1096-102. PubMed ID: 6289941
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy with nucleoside analogs and alkylating agents.
Johnston JB; Verburg L; Shore T; Williams M; Israels LG; Begleiter A
Leukemia; 1994 Apr; 8 Suppl 1():S140-3. PubMed ID: 8152282
[TBL] [Abstract][Full Text] [Related]
17. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia.
Yu AL; Bakay B; Kung FH; Nyhan WL
Cancer Res; 1981 Jul; 41(7):2677-82. PubMed ID: 6972800
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of DNA repair by deoxyadenosine in resting human lymphocytes.
Seto S; Carrera CJ; Wasson DB; Carson DA
J Immunol; 1986 Apr; 136(8):2839-43. PubMed ID: 2870121
[TBL] [Abstract][Full Text] [Related]
19. S-adenosylhomocysteine hydrolase inactivation and purine toxicity in cultured human T- and B-lymphoblasts.
Young GJ; Hallam LJ; Jack I; Van Der Weyden MB
J Lab Clin Med; 1984 Jul; 104(1):86-95. PubMed ID: 6330251
[TBL] [Abstract][Full Text] [Related]
20. 2'-deoxyadenosine induces apoptosis in rat chromaffin cells.
Wakade AR; Guo X; Palmer KC; Kulkarni JS; Przywara DA; Wakade TD
J Neurochem; 1996 Dec; 67(6):2273-81. PubMed ID: 8931458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]